Completely humanized monoclonal neutralizing antibody for tetanus toxin and application of neutralizing antibody

A monoclonal antibody and tetanus toxin technology, applied in the field of biomedicine, can solve the problems of follow-up research reports without functional test data

Active Publication Date: 2018-07-24
CHANGCHUN BCHT BIOTECH
View PDF5 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although this work shows that the toxin neutralization activity and mouse survival data are described in

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Completely humanized monoclonal neutralizing antibody for tetanus toxin and application of neutralizing antibody
  • Completely humanized monoclonal neutralizing antibody for tetanus toxin and application of neutralizing antibody
  • Completely humanized monoclonal neutralizing antibody for tetanus toxin and application of neutralizing antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] Example 1 Preparation of fully human anti-tetanus toxin neutralizing antibody

[0067] 1. Sorting cells

[0068] A healthy volunteer was injected with 1500 IU tetanus toxoid (vaccine), and blood samples were collected on day 7. Then isolate mononuclear cells (PBMC); then use a BD FACSria flow cytometer to sort out plasma cells from PBMC, and place the single cells with good morphology in a 96-well PCR plate so that each well contains a memory B cell, Store in -80°C refrigerator for later use.

[0069] 2. Isolation of antibody variable region genes

[0070] Add 0.5 μM constant region primers of heavy and light chains of each subtype to a 96-well plate containing a single B cell and Superscript III reverse transcriptase, and incubate at 37°C for 1 hour; carry out PCR amplification according to the following parameters: 95°C for 15 minutes ; 95°C 1min, 55°C 1min, 72°C 1min, 30cycles; 72°C 10min; 4°C 5min. The product cDNA was stored at -20°C.

[0071] Using the above ...

Embodiment 2

[0089] Example 2 Detection of binding activity of TRN0010 antibody

[0090] Use the same ELISA method mentioned above to detect the binding activity of the expressed and purified antibody: use tetanus toxin as the antigen, and coat the 96-well ELISA plate after diluting the antigen 10 times with the coating solution, and coat each well with 100 μl overnight at 4°C. were blocked with blocking solution at room temperature for 2 h. Incubate 3-fold diluted TRN0010 antibody as the primary antibody at room temperature for 2 hours, and incubate with HRP / anti-His-tag (1:2000 dilution) as the secondary antibody at room temperature for 1 hour, add substrate chromogenic solution 100 μl / well, and keep away from light at room temperature After standing for 5 minutes, stop the reaction with 2M sodium sulfate, perform colorimetric detection with a wavelength of 450nm, and analyze the results.

[0091] The result is as figure 2 As shown, after diluting the expressed and purified TRN0010 an...

Embodiment 3

[0092] Example 3 Affinity detection of TRN0010 antibody

[0093] First, the CM5 chip was coupled with the capture molecules, and then the dextran surface of the chip was activated. The coupling amount was determined by the injection time, and finally the CM5 chip was used to capture the molecule capture ligand: the prepared fully human anti-tetanus neutralizing antibody was used as Ligand. The tetanus toxoid was diluted with HBS-EP buffer as the analyte, and the analyte flowed through the chip in sequence with increasing concentration, and the signal curves were respectively obtained. Each concentration was regarded as one cycle, and after completing one cycle, the chip was regenerated with 10 mmol / L glycine-hydrochloric acid to return to the original state of unbound antigen. BiaCore X-100 System software was used to analyze the affinity and kinetics of monoclonal antibody binding to tetanus toxoid (antigen).

[0094] The result is as image 3 As shown in Table 1, the diss...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a completely humanized monoclonal neutralizing antibody for a tetanus toxin. The completely humanized anti-tetanus toxin neutralizing antibody is developed via a comprehensivehigh-throughput completely humanized monoclonal antibody research and development technical platform. The neutralizing antibody is high in affinity and specificity and has an important significance onprevention and treatment of tetanus infection.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to a fully human monoclonal neutralizing antibody against tetanus toxin and its application. Background technique [0002] Tetanus toxin is a neuroprotein toxin produced by Bacillus tetani, through the release of inhibitory neurotransmitters, causing hyper-reflex reactions and striated muscle spasms; it can lead to generalized muscle tonic spasms in patients, which can develop into severe cases or cause systemic Death from exhaustion and suffocation is called tetanus. Tetanus toxin is one of the most toxic toxins known. The lethal dose of purified tetanus toxin to mice is 0.1ng / kg, the lethal dose to guinea pigs is 0.3ng / kg, and the lethal dose to humans is estimated to be 0.25 ng / kg. Tetanus toxin is extremely toxic and acts rapidly. When a patient is infected with tetanus, there are a large number of tetanus bacillus and tetanus toxin in the body, the only effective preve...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K16/12C12N15/13C12N15/85C12N5/10A61K39/40A61P31/04
CPCA61K2039/505C07K16/1282
Inventor 廖化新王月明袁晓辉
Owner CHANGCHUN BCHT BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products